The incidence of fungal peritonitis (FP) and the fungi that caused FP were evaluated in 422 patients treated with peritoneal dialysis. During an 11-year period, 804 episodes of peritonitis occurred, 46 (5.7%) of which were caused by fungi. Treatment was successful for 39 patients. Early diagnosis of FP and prompt therapy decreases morbidity and mortality.
ceived PD treatment during the period of January 1991 through December 2001.
Patients and methods. The frequency, diagnosis, and treatment of FP during an 11-year period (January 1991 through December 2001) were retrospectively studied in 422 patients with end-stage renal failure treated by PD (405 were treated with continuous ambulatory PD, and 17 were treated with automated PD). The diagnosis of peritonitis was based on clinical manifestations (abdominal pain, nausea, and fever) and a cloudy appearance of the dialysis effluent (DE), with a WBC count of 1100 cells/mm 3 (with neutrophil predominance). Diagnosis was confirmed by the isolation of the same fungus from 11 DE sample. The processing of the DE sample included a leukocyte count, centrifugation of cloudy DE, and Gram and Giemsa staining of the pellet (i.e., the sediment of peritoneal dialysis effluent). For bacterial culture, DE samples were inoculated onto blood agar and MacConkey agar, and 5 mL of DE was added to double-concentration thioglycollate broth. For fungal culture, DE samples were inoculated onto Sabouraud dextrose agar. All incubation was performed at 37ЊC for 7 days.
For the identification of C. albicans, a screening test of the germination tube was initially performed. If the result was negative (for C. albicans), the Api-System CAUX20 or Api-System ID 32C (bioMérieux) was used. Molds were identified on the basis of their macroscopic and microscopic appearances after culture on Sabouraud dextrose agar and potato dextrose agar, which induces sporulation.
Susceptibility testing of all isolated Candida species to the antifungal drugs 5-fluorocytosine, amphotericin B, nystatin, miconazole, econazole, and ketoconazole was performed first by the method of Drouhet and Dupont [5] (i.e., the antifungal drug was absorbed in paper disks that were put onto a semisynthetic medium [Pasteur]), and second by determination of the MIC with use of the commercially available ATB-fungus test (bioMérieux). In addition, 30 isolates of Candida species underwent susceptibility testing by the National Committee for Clinical Laboratory Standards (NCCLS) M27-A method, with some modification [6] . The isolates were tested for susceptibility to amphotericin B, fluconazole, 5-fluorocytosine, itraconazole, ketoconazole, and voriconazole.
The treatment of FP included administration of amphotericin B (20-25 mg iv q.d.) and 5-fluorocytosine (50 mg in every 2-L PD bag) for 14 days, followed by administration of fluconazole (100 mg po q.d.) for 1 month. If there was no clinical improvement, the PD catheter was removed on the fifth to 
seventh day of treatment, intraperitoneal administration of 5-fluorocytosine was stopped, and the patient was treated by hemodialysis for 4-6 weeks. After this period, a new catheter was inserted in patients who recommenced PD treatment.
Results. During the 11-year study period, 804 episodes of peritonitis were observed. In 46 of these episodes, which occurred in 44 patients (23 men and 21 women), fungi were identified as etiological agents. Two female patients each had 2 episodes of FP. At the time of diagnosis of FP, the mean age of the 44 patients was 59.4 years (range, 3-80 years), and the mean duration of PD (‫ע‬SD) was months (range, 34.8 ‫ע‬ 30.4 0.5-96 months).
The primary renal disease leading to end-stage renal failure was diabetic nephropathy in 9 patients, chronic interstitial nephritis in 8 patients, chronic glomerulonephritis in 6 patients, polycystic kidney disease in 7 patients, amyloidosis in 4 patients, and nephrosclerosis in 4 patients. The disease was unknown for the remaining 6 patients.
At admission to the hospital, all patients had clinical signs and symptoms of peritonitis and cloudy DE samples. At presentation, the signs and symptoms of FP were not different from those of bacterial peritonitis. WBC counts were 150-9000 cells/mm 3 , with neutrophil predominance. Gram staining of DE samples revealed budding yeasts or hyphae for 9 (19.6%) of 46 episodes in which the presence of fungi was confirmed by culture. In the remaining 37 episodes, the results of Gram staining were negative, and dialysate cultures revealed fungi after a mean period of 1.5 days (range, 1-5 days).
Among the causative organisms (table 1) , various Candida species accounted for 89.1% of all episodes of FP, with C. albicans being by far the most common isolate. Filamentous fungi were identified in 4 cases of FP, the details of which have been published elsewhere [7, 8] . Aspergillus niger was identified in a 37-year-old woman shortly after the initiation of PD because of rejection of a kidney transplant. Atypical Paecilomyces variotii was isolated from a 65-year-old woman with FP. The remaining 2 filamentous fungi that caused FP in 2 women (ages, 76 and 57 years old) were Fusarium solani and Acremonium strictum, respectively. In 15 patients, FP followed an episode of bacterial peritonitis that was treated with antibiotics.
All isolates tested by methods 1 and 2 were susceptible to the antifungal drugs amphotericin B, 5-fluorocytosine, nystatin, miconazole, econazole, and ketoconazole. The results yielded using the NCCLS M27-A method are presented in table 2. All blood culture results were negative, and there was no evidence of disseminated fungal disease.
Treatment was successful in 39 (88.6%) of 44 patients. The PD catheter was removed on the fifth to seventh day after the initiation of the therapy in 40 episodes (87%). After treatment, 17 patients (38.6%) recovered from infection and continued PD, 20 (45.5%) switched to hemodialysis, and 7 (15.9%) died. Our results, as well as the results from other reports [2, 3, [9] [10] [11] [12] [13] [14] , are shown in table 3.
Discussion. FP is a serious complication of treatment with PD, with high rates of morbidity and mortality. The incidence of FP (5.7% of episodes of peritonitis) at our health care center is within the range of the reported incidence of 2%-10.2% [1] [2] [3] [9] [10] [11] [12] [13] [14] [15] . The duration of PD treatment before the diagnosis of FP in our patients (0.5-96 months) is also similar to the reported ranges of 1-72 months [3] and 2-69 months [2] .
In patients undergoing PD, many factors are present that are liable to favor the occurrence of FP, including rupture of the cutaneous barrier, as a result of the presence of the catheter, and reduced cellular immunity during chronic end-stage renal disease. The relative rarity of fungal infection suggests that other factors are also involved, but neither age nor sex seems to be implicated. On the other hand, 34% of the patients with FP in this study had a recent episode of bacterial peritonitis and had received antibiotics. It seems that hospitalization, recent episodes of bacterial peritonitis, and the administration of antibiotics are involved in the pathogenesis of FP [9, 16] . The role of diabetes has been variously evaluated in different series [3, 16] , but, in most studies, it does not seem to predispose patients to FP.
Our results confirm the absence of specificity of clinical manifestations and cell counts in DE in our patients with FP [9, 10, 17] . On the other hand, Gram staining of centrifuged Candida parapsilosis ( NOTE. NS, not specified.
DE specimens was definitely a useful test, because it permitted the detection of budding yeasts or pseudohyphae in 19.6% of episodes of FP. The proportion of positive test results reported by other authors was 10%-50% [3, 9] . The isolation of fungus from DE culture confirmed the diagnosis of FP. The most common fungus was Candida species, a yeast that grows easily on medium used for culture of bacteria, such as blood agar. It does not seem necessary, for routine purposes, to grow cultures on specific fungal media, as suggested by Rubin et al. [18] . The most common species of Candida to have caused FP in our patients were C. albicans (36.9%) and Candida parapsilosis (23.9%), as has also been reported by others [2, 16, 18, 19] . Although filamentous fungi rarely invade the PD catheter and cause FP [18] , they were isolated in 4 episodes of FP. To our knowledge, the patient with FP caused by A. niger was the only one to have survived of 7 reported patients with PD caused by Aspergillus species [7, 20] . In the relevant literature, there are 13 reported cases involving P. variotii [8, 21] , 12 cases involving Fusarium species (one of which was due to F. solani) [8, 22] , and 2 cases involving Acremonium species (one of which was due to Acremonium kiliense, and the other of which was due to A. strictum) [23, 24] .
Susceptibility testing revealed that amphotericin B was the only antifungal agent to which all recovered organisms were susceptible. On the other hand, 4 of 15 isolates of C. albicans with a high MIC of fluconazole had high MICs of other azoles, too.
With regard to treatment of FP, most authors agree that removal of the PD catheter is not adequate and that administration of antifungal agents is imperative. In this study, the PD catheter was removed during 40 (87%) of 46 episodes of FP, which is higher than the rate described in most reports [2, 17] . This may have contributed to the low percentage of deaths in our study (15.9%), which is comparable to the incidence of 17%-24% reported elsewhere [9, 10] , although even higher mortality rates have been reported by some authors [3, 15, 18] .
In conclusion, FP is a serious complication of PD leading to loss of ultrafiltration and discontinuation of PD treatment. The most frequently isolated fungi are C. albicans and C. parapsilosis; filamentous fungi are found only rarely. The Api-System CAUX20 and Api-System ID 32C methods seem to be simple means for yeast identification. The ATB-fungus method for antifungal susceptibility testing is simple, and the result is ready in 24 h. Treatment requires administration of antifungal agents, especially amphotericin B, to which organisms are still susceptible, and early removal of the peritoneal catheter. The prompt diagnosis of FP and the early institution of therapy decrease the rates of morbidity and mortality.
